reglab/statecodes huggingface dataset:
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 505 - Anatomical Gifts › Subchapter 7 - Eye Banks › Section 310:505-7-7 - Technical operations personnel

Current through Vol. 41, No. 20, July 1, 2024
(a)
				Each eye bank shall employ sufficient technical operations personnel to meet
				the procurement, testing, quality control, and quality assurance needs for the
				number and type of eyes and eye tissue units recovered, processed, stored, and
				distributed to ensure a that safe and reliable product is provided.
(b) Each eye bank shall employ at least one
				person holding current certification as a Certified Eye Bank Technician by the
				EBAA or other nationally recognized accrediting or certifying organization for
				eye banks and personnel approved by the Commissioner.
Added at 18 Ok Reg 1711,
				  eff 5-25-01
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 505 - Anatomical Gifts › Subchapter 7 - Eye Banks › Section 310:505-7-8 - Tissue distribution

Current through Vol. 41, No. 20, July 1, 2024
Each eye bank shall give priority to the Oklahoma medical
				  community and to the needs of patients being treated in
				  Oklahoma.
Added at 18 Ok Reg 1711,
				  eff 5-25-01
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 505 - Anatomical Gifts › Subchapter 7 - Eye Banks › Section 310:505-7-9 - Annual report

Current through Vol. 41, No. 20, July 1, 2024
(a) Each eye bank
				in Oklahoma shall prepare and submit an annual report to the Department based
				on the previous calendar year's twelve month period of January 1st, through
				December 31st.
(b) Annual reports
				shall be provided to the Department by March 31st of each calendar
				year.
(c) During an eye bank's
				first year of operation, the annual report shall be based on the period from
				the first day of operation to December 31st of that year.
(d) Each annual report shall include at least
				the following information:
(1) The
				accreditation status of the eye bank;
(2) A report of all regulatory,
				accreditation, or internal inspections which result in findings that impact the
				quality of the product or services provided by the eye bank;
(3) The names and certification statuses of
				all technical personnel who meet the requirements of OAC
				310:505-7-7.
(4) The name and qualifications of the
				current medical director including evidence the medical director is a board
				certified ophthalmic surgeon and currently licensed to practice medicine in
				Oklahoma;
(5) The numbers and
				geographic origins of all donor corneas and whole eyes procured; and
(6) The number and geographic destinations of
				corneas and other parts of eyes.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 510 - Care of Eyes for Newborn Children [Revoked] › Subchapter 1 - General Provisions [Revoked] › Section 310:510-1-1 - Purpose [REVOKED]

Current through Vol. 41, No. 20, July 1, 2024
Revoked at 28 Ok Reg
				  1060, eff 6-11-11
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 510 - Care of Eyes for Newborn Children [Revoked] › Subchapter 3 - Approved Antiseptics [Revoked] › Section 310:510-3-1 - Approved antiseptics [REVOKED]

Current through Vol. 41, No. 20, July 1, 2024
Revoked at 28 Ok Reg
				  1060, eff 6-11-11
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 510 - Care of Eyes for Newborn Children [Revoked] › Subchapter 5 - Recommendations [Revoked] › Section 310:510-5-1 - Recommendations [REVOKED]

Current through Vol. 41, No. 20, July 1, 2024
Revoked at 28 Ok Reg
				  1060, eff 6-11-11
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 1 - General Provisions › Section 310:512-1-1 - Purpose

Current through Vol. 41, No. 20, July 1, 2024
The rules in this Chapter establish procedures and standards
				  for childhood lead screening, assessment, poison prevention, and reporting as
				  authorized under the provisions of Title 63 O.S. Section
				  1-114.1.
Added at 12 Ok Reg 3055,
				  eff 7-27-95
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 1 - General Provisions › Section 310:512-1-2 - Criteria

Current through Vol. 41, No. 20, July 1, 2024
(a) The Infant and Children's Health Advisory
				Council shall advise the Oklahoma State Board of Health on the establishment of
				rules for the prevention of childhood lead poisoning which shall include risk
				assessment, blood lead screening, laboratory assays, sample collection,
				reporting, lead hazard control, and rules related to the role of the provider
				such as: follow-up, diagnosis and treatment, developmental screening, referral
				for environmental assessments and lead hazard control, and parent
				education.
(b) All health care
				providers shall comply with the following procedures for blood lead
				screening.
(c) After sufficient
				statewide data collection and documented incidence of low lead exposure, the
				Commissioner of Health may exempt a community or county from universal lead
				screening.
Added at 12 Ok Reg 3055,
				  eff 7-27-95
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 1 - General Provisions › Section 310:512-1-3 - Lead poisoning prevention program

Current through Vol. 41, No. 20, July 1, 2024
(a) The Department maintains a lead poisoning
				prevention program. This program is responsible for establishing and
				coordinating activities to prevent lead poisoning and to minimize risk of
				exposure to lead.
(b) The
				Department enforces rules for screening children for lead poisoning, and for
				follow-up of children who have elevated blood lead levels.
(c) The Department may enter into interagency
				agreements to coordinate lead poisoning prevention, exposure reduction,
				identification and treatment activities and lead reduction activities with
				other federal, state and local agencies and programs.
(d) The Department maintains a statewide
				surveillance system of all Oklahoma resident's blood lead levels provided such
				information is monitored as confidential except for disclosure for medical
				treatment purposes or disclosure of non-identifying epidemiological
				data.
(e) The Department develops
				and implements public education and community outreach programs on lead
				exposure, detection and risk reduction.
Added at 12 Ok Reg 3055,
				  eff 7-27-95
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 3 - Risk Assessment, Screening and Management › Section 310:512-3-1 - Risk assessment and screening criteria

Current through Vol. 41, No. 20, July 1, 2024
(a) All children in Oklahoma, 6 months to 72
				months of age shall be assessed for blood lead exposure utilizing the risk
				assessment questionnaire as defined in paragraph (c) as part of each periodic
				health care visit occurring at age 6, 12, and 24 months and age 3 years, 4
				years and 5 years.
(b) All children
				in Oklahoma shall have a blood lead screening test as part of each periodic
				health care visit occurring at age 12 and 24 months of age or at any age after
				age 24 months up to age 72 months, if not previously tested for blood
				lead.
(c) A risk assessment
				questionnaire based on recommendations from the CDC and approved by the
				Department before implementation should include questions related to the
				following:
(1) Does the child live in or
				frequently visit a home built before 1978?
(2) Does the child have a sibling or playmate
				with an elevated blood lead level?
(3) Is the child eligible for Medicaid, WIC,
				or Head Start?
(4) Does the child
				live with someone who has a job or hobby that may involve lead (example:
				jewelry making, building renovation or repair, working with automobile
				batteries, lead solder, or battery recycling)?
(5) Does the child eat or mouth trinkets or
				items that contain lead?
(6) Does
				the child live in an area identified as a high-risk target area by the
				Program?
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 3 - Risk Assessment, Screening and Management › Section 310:512-3-2.1 - Primary health care provider responsibilities for risk assessment and screening

Current through Vol. 41, No. 20, July 1, 2024
(a) Every primary
				health care provider who provides a periodic health care visit to a child at
				age 6, 12, and 24 months and age 3, age 4 and 5 years shall assess the child
				for risk of lead exposure using the LERAQ, or suitable risk assessment
				questionnaire approved by the Department.
(b) For children at high risk for lead
				exposure according to the LERAQ, or suitable risk assessment questionnaire, the
				primary health care provider shall perform a blood lead test beginning at 6
				months of age, or when initially assessed, if older.
(c) Every primary health care provider who
				provides a periodic health care visit to a child shall order an initial
				capillary or venous blood lead screening test at age 12 and 24 months, or at
				any age after age 24 months up to age 72 months if never tested.
(d) Every primary health care provider who
				provides a periodic health care visit to a child at age 6, 12, and 24 months
				and age 3, age 4, and 5 years shall:
(1) Give
				oral or written anticipatory guidance to a parent or guardian on prevention of
				childhood lead poisoning, including, at minimum, the information that children
				can be harmed by exposure to lead, especially deteriorating or disturbed
				lead-based paint and the dust from it, and are particularly at risk of lead
				poisoning from the time the child begins to crawl until 72 months of age;
				and
(2) Discuss the child's blood
				lead test results with the child's family and any necessary follow
				up.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 3 - Risk Assessment, Screening and Management › Section 310:512-3-3 - Blood lead screening tests

Current through Vol. 41, No. 20, July 1, 2024
(a)
Capillary sample for blood lead testing.
Capillary blood specimens
				are acceptable for initial blood lead screening if appropriate collection
				procedures are followed to minimize the risk of environmental lead
				contamination. A capillary blood lead sample may be obtained for confirmation
				of an elevated blood lead level less than 10 µg/dL when a venous sample
				is not obtainable.
(b)
Venous
				sample for blood lead testing.
Venous blood is the preferred specimen
				for blood lead analysis and should be used for lead measurement whenever
				practical. A venous sample is required for confirmation of blood lead
				concentration equal to or greater than 10 µg/dL and preferred for
				confirmation of an elevated blood lead level less than 10
				µg/dL.
(c)
Point-of-Care instruments.
Point-of-Care instruments shall not be
				used to confirm elevated blood lead levels even if the sample is collected by
				venipuncture.
Added at 12 Ok Reg 3055,
				  eff 7-27-95
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 3 - Risk Assessment, Screening and Management › Section 310:512-3-4.1 - Health care provider responsibilities for follow-up after screening

Current through Vol. 41, No. 20, July 1, 2024
(a) Health care providers shall provide or
				make reasonable efforts to ensure the provision of confirmation and follow-up
				testing for each child with an elevated blood lead level above the reference
				level.
(b) If the initial blood
				lead test result is below the reference level on either a venous or capillary
				sample, the health care provider shall retest the child annually if answers on
				the LERAQ or suitable risk assessment questionnaire indicate continuing high
				risk for lead exposure.
(c) For
				each child who has an elevated blood lead level at or above the reference
				level, the health care provider shall take those actions that are reasonably
				and medically necessary and appropriate based upon the child's blood lead level
				to reduce, to the extent possible, the child's blood lead level below the
				reference level. Such actions may include the following:
(1) Education of a parent or guardian on lead
				hazards and lead poisoning;
(2)
				Clinical evaluation for complication of lead poisoning;
(3) Follow-up blood lead analyses as
				indicated based on level of elevation and period of time;
(4) Developmental screening;
(5) Referral to the Department for an
				environmental investigation for a single venous blood lead test result equal to
				or greater than 10 µg/dL; and
(6) Chelation therapy should be considered
				and, when possible, a medical toxicologist, provider experienced in chelation
				therapy, or pediatric environmental health specialist should be consulted for a
				child with a blood lead test greater than 45 µg/dL.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 3 - Risk Assessment, Screening and Management › Section 310:512-3-5 - Reporting requirements

Current through Vol. 41, No. 20, July 1, 2024
(a)
Laboratory.
(1) Laboratories
				shall report the results of all blood lead tests performed on persons who are
				residents of Oklahoma to the Childhood Lead Poisoning Prevention Program. These
				reports are confidential and may be utilized only for the purpose of assuring
				service delivery, program administration, data analysis, and
				evaluation.
(2) Federal CLIA
				regulations at Title 42, of the Code of Federal Regulations, Section
				493.1241 (relating to standards
				for test requests), require that laboratory requisitions contain sufficient
				patient data that must include patient's name, sex, date of birth, date of
				collection, test(s) to be performed, the source of the specimen, name and
				address of person requesting the test, as well as "Any additional information
				relevant and necessary for a specific test to ensure accurate and timely
				testing and reporting of results, including interpretation, if applicable."
				Laboratories shall report the following information to the Childhood Lead
				Poisoning Prevention Program by electronic data transmission: name, date of
				birth, sex, address, county of residence, type of sample (venous or capillary),
				blood lead level, health care provider ordering the test, laboratory
				identifiers, date the sample was collected, the date of analysis, and
				additional information already available such as race, ethnicity, Medicaid
				status and/or Medicaid Number. The laboratory receiving the sample from the
				health care provider taking the sample shall assure that the laboratory
				requisition slip is fully completed and includes the information required
				pursuant to the Subsection. In the event electronic submission is not
				available, lab reports must be submitted by a method and format approved by the
				Oklahoma Childhood Lead Poisoning Prevention Program.
(3) Test results that are reported to the
				Childhood Lead Poisoning Prevention Program have the following time limits:
(A) Results of all blood lead levels less
				than the reference level at a minimum of a monthly basis.
(B) Results of all blood lead levels equal to
				or greater than the reference level at a minimum of a weekly basis and if
				possible daily.
(4) All
				clinical laboratories shall notify the health care provider ordering the blood
				lead test when the results of any analysis in a child up to 72 months of age is
				equal to or greater than 10 µg/dL within 24 hours of the date of the
				analysis.
(5) Nothing in this
				Subsection shall be construed to relieve any laboratory from reporting results
				of any blood lead analysis to the physician, or other health care provider who
				ordered the test or to any other entity as required by State, Federal or local
				statutes or regulations or in accordance with accepted standard of
				practice.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 3 - Risk Assessment, Screening and Management › Section 310:512-3-6 - Fees

Current through Vol. 41, No. 20, July 1, 2024
The county health department may collect a fee for a blood
				  lead laboratory sample analysis, a fee for collection of a blood lead sample,
				  or a fee for an environmental investigation, as may be indicated. Any fee
				  collected shall not exceed the reasonable cost of providing the service or the
				  Medicaid reimbursement rate allowed for the service, whichever is lower. Any
				  individual consenting to a blood lead test shall be informed of the specific
				  fee prior to the collection of the laboratory specimen.
Added at 27 Ok Reg 2521,
				  eff 7-25-10
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 512 - Childhood Lead Poisoning Prevention Rules › Subchapter 3 - Risk Assessment, Screening and Management › Section 310:512-3-7 - Inability to pay

Current through Vol. 41, No. 20, July 1, 2024
Persons requesting blood lead level testing will not be
				  denied a blood lead sample analysis or, if indicated, an environmental
				  investigation because of the inability to pay.
Added at 27 Ok Reg 2521,
				  eff 7-25-10
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 1 - Disease and Injury Reporting › Section 310:515-1-1 - Purpose

Current through Vol. 41, No. 20, July 1, 2024
The rules in this Chapter implement the Communicable
				  Diseases Reporting Regulations, 63 O.S. §§1-104, 1-106, 1-502, and
				  1-503.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 1 - Disease and Injury Reporting › Section 310:515-1-2 - Diseases to be reported

Current through Vol. 41, No. 20, July 1, 2024
The diseases listed in this Chapter must be reported, along
				  with patient identifiers, demographics, and contact information, to the
				  Department upon discovery as dictated in sections OAC
				  310:515-1-3
				  and OAC
				  310:515-1-4.
				  Laboratories reporting diseases described in
				  310:515-1-3,
				  310:515-1-4(1)
				  and
				  310:515-1-4(2),
				  or as may be otherwise required to be reported by OSDH, shall be reported
				  electronically using the manner and format prescribed by the State Commissioner
				  of Health.
Amended at 17 Ok Reg
				  2942, eff 7-13-00; Amended at 19 Ok Reg 1285, eff 5-28-02; Amended at 24 Ok Reg
				  1978, eff 6-25-07; Amended at 27 Ok Reg 2522, eff
				  7-25-10;
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 1 - Disease and Injury Reporting › Section 310:515-1-3 - Diseases and conditions to be reported immediately

Current through Vol. 41, No. 20, July 1, 2024
The following diseases/conditions associated with humans
				  must be reported by any health practitioner or laboratory personnel to the OSDH
				  electronically via secure electronic data transmission and by telephone (405
				  426-8710) immediately upon suspicion, diagnosis, or testing.
(1) Anthrax (
Bacillus
				anthracis
).
(2)
				Bioterrorism - suspected disease.
(3) Botulism (
Clostridium
				botulinum
).
(4) Diphtheria
				(Corynebacterium diphtheriae).
(5)
				Free-living amebae infections causing primary amebic meningoencephalitis
				(
Naegleria fowleri
).
(6) Hepatitis B during pregnancy
				(HBsAg+).
(7) Measles
				(Rubeola).
(8) Meningococcal
				invasive disease (
Neisseria meningitidis
).
(9) Novel coronavirus.
(10) Novel influenza A.
(11) Outbreaks of apparent infectious
				disease.
(12) Orthopox viruses
				(i.e., Smallpox, Monkeypox).
(13)
				Plague.
(14)
				Poliomyelitis.
(15)
				Rabies.
(16) Typhoid fever
				(
Salmonella
Typhi).
(17) Viral hemorrhagic fever.
Amended at 9 Ok Reg 485,
				  eff 1-1-92 (emergency); Amended at 9 Ok Reg 1429, eff 5-1-92; Amended at 17 Ok
				  Reg 2942, eff 7-13-00; Amended at 19 Ok Reg 1285, eff 5-28-02; Amended at 20 Ok
				  Reg 2366, eff 7-11-03; Amended at 24 Ok Reg 1978, eff 6-25-07; Amended at 26 Ok
				  Reg 2033, eff 6-25-09; Amended at 27 Ok Reg 2522, eff 7-25-10; Amended at 29 Ok
				  Reg 1601, eff 7-12-12
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 1 - Disease and Injury Reporting › Section 310:515-1-5 - Diseases to be reported by physicians and infection control practitioners [REVOKED]

Current through Vol. 41, No. 20, July 1, 2024
Revoked at 9 Ok Reg 485,
				  eff 1-1-92 (emergency); Revoked at 9 Ok Reg 1429, eff
				  5-1-92
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 1 - Disease and Injury Reporting › Section 310:515-1-6 - Additional diseases may be designated

Current through Vol. 41, No. 20, July 1, 2024
The Commissioner of Health may designate any disease or
				  condition as reportable for a designated period of time for the purpose of
				  enhanced public health surveillance or special investigation.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 1 - Disease and Injury Reporting › Section 310:515-1-7 - Control of Communicable Diseases Manual

Current through Vol. 41, No. 20, July 1, 2024
The OSDH adopts the most recently published edition of the
				  publication, "Control of Communicable Diseases Manual," published by the
				  American Public Health Association, as a guideline for the prevention and
				  control of communicable diseases.
Amended at 17 Ok Reg
				  2942, eff 7-13-00; Amended at 24 Ok Reg 1978, eff 6-25-07; Amended at 26 Ok Reg
				  2033, eff 6-25-09
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 1 - Disease and Injury Reporting › Section 310:515-1-8 - Organisms/specimens to be sent to the Public Health Laboratory

Current through Vol. 41, No. 20, July 1, 2024
(a) Isolates or
				appropriate specimens of the following organisms shall be sent to the OSDH
				Public Health Laboratory for typing.
(1)
Bacillus anthracis.
(2)
Brucella
spp.
(3) Carbapenem-resistant
Enterobacteriaceae.
(4)
E. coli O157, O157:H7
,
				or a Shiga toxin producing
E. coli
.
(5)
Francisella
				tularensis.
(6)
Haemophilus influenzae
(sterile site).
(7)
Listeria monocytogenes
(sterile site).
(8)
Mycobacteriumtuberculosis
.
(9)
Neisseria meningitidis
(sterile site).
(10)
Plasmodium
spp.
(11)
Salmonella
spp.
(12)
Vibrionaceae
family (
Vibrio
spp.,
Grimontia
spp.,
Photobacterium
spp. and other
				genera in the family).
(13)
Yersinia
spp.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 3 - Disclosures and Uses of Disease Prevention and Control Information › Section 310:515-3-1 - General provisions

Current through Vol. 41, No. 20, July 1, 2024
Information received, created and/or maintained by the
				  Department pursuant to the provisions of the Public Health Code relating to
				  Disease Prevention and Control is confidential and shall be protected from
				  disclosure unless release or disclosure is sought in accordance with this
				  subchapter or is otherwise authorized by law.
Added at 24 Ok Reg 1978,
				  eff 6-25-07
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 3 - Disclosures and Uses of Disease Prevention and Control Information › Section 310:515-3-2 - Disclosures upon written consent

Current through Vol. 41, No. 20, July 1, 2024
Information received, created and/or maintained by the
				  Department pursuant to the provisions of the Public Health Code relating to
				  Disease Prevention and Control may be disclosed to a requesting person upon the
				  presentation of a valid written consent executed by the person whose
				  information is being kept confidential or the legal guardian or legal custodian
				  of such person, under the following conditions:
(1) If the written consent is delivered to
				the Department by a person other than the person whose information is being
				kept confidential or the legal guardian or legal custodian of such person, the
				written consent must either be verified under oath or contain some form of
				attestation certifying or confirming the authenticity of the signature of the
				person whose information is being kept confidential or the legal guardian or
				legal custodian of such person.
(2)
				The written consent must advise the person whose information is being kept
				confidential or the legal guardian or legal custodian of such person the
				identity of all persons and/or entities who are likely or intended to receive
				or view the information sought to be released or disclosed. The identity must
				include the full name, address and title or office of such person or entity
				identified in the written consent. The written consent must state that the
				information will not be released or disclosed to any person or entity not so
				identified.
(3) The written consent
				must include a notice thereon, in bold typeface, that the information
				authorized for release may include records that may indicate the presence of a
				communicable or venereal disease, which may include, but are not limited to,
				diseases such as hepatitis, syphilis, gonorrhea and the human immunodeficiency
				virus, also known as Acquired Immune Deficiency Syndrome (AIDS).
(4) The written consent must advise the
				person whose information is being kept confidential or the legal guardian or
				legal custodian of such person of the provisions of 63 O.S.Supp.2005, §
				1-502.2.
Added at 24 Ok Reg 1978,
				  eff 6-25-07
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 3 - Disclosures and Uses of Disease Prevention and Control Information › Section 310:515-3-3 - Grounds for denial

Current through Vol. 41, No. 20, July 1, 2024
A person whose information is being kept confidential or the
				  legal guardian or legal custodian of such person may be denied access to
				  information if the information was obtained from someone other than a health
				  care provider under a promise of confidentiality, the access requested would be
				  reasonably likely to reveal the confidential source of the information and the
				  requested information cannot be presented in a manner that preserves the
				  confidentiality of the source. The Department incorporatesHIPAA, 42 C.F.R.
				  § 164.524(a)(2)(v)(2006) only as guidance in applying this
				  section.
Added at 24 Ok Reg 1978,
				  eff 6-25-07
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 515 - Communicable Disease and Injury Reporting › Subchapter 3 - Disclosures and Uses of Disease Prevention and Control Information › Section 310:515-3-4 - Disclosures permitted without a written consent

Current through Vol. 41, No. 20, July 1, 2024
Information received, created and/or maintained by the
				  Department pursuant to the provisions of the Public Health Code relating to
				  Disease Prevention and Control may, without first obtaining a written consent
				  in accordance with this subchapter, be disclosed, shared and/or disseminated
				  with health professionals engaged in activities described or identified in the
				  provisions of the Public Health Code relating to Disease Prevention and
				  Control.
Added at 24 Ok Reg 1978,
				  eff 6-25-07
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 517 - Novel Coronavirus Regulations › Subchapter 1 - General Provisions › Section 310:517-1-1 - Purpose

Current through Vol. 41, No. 20, July 1, 2024
The purpose of this chapter is to collect data determined to
				  be critical to assess the likelihood of, and to prevent, a future public health
				  emergency related to novel coronavirus and to establish the specific data
				  reporting requirements and the procedures for submission of the data to the
				  Oklahoma State Department of Health. The rules in this Chapter implement in
				  part, the communicable disease reporting laws in Title 63 O.S. §§
									1-104
				  and
				  1-106,
				  Commissioner of Health, Title 63 O.S. §
									1-502,
				  Prevention and Control of Disease and Title 63 O.S. §
									1-503, Reports
				  of Disease. The rules set forth the conditions under which hospitals are
				  allowed to expand or modify bed capacity.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 517 - Novel Coronavirus Regulations › Subchapter 2 - Novel Coronavirus Reports › Section 310:517-2-1 - Specimens to be sent to the Public Health Laboratory

Current through Vol. 41, No. 20, July 1, 2024
Hospitals and laboratories must send, at a minimum, 10% of
				  their weekly positive novel coronavirus specimens to the OSDH Public Health
				  Laboratory for variant testing. The collection, packaging, and shipping of the
				  positive novel coronavirus specimen must be in accordance with OSDH Public
				  Health Laboratory guidelines.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 517 - Novel Coronavirus Regulations › Subchapter 2 - Novel Coronavirus Reports › Section 310:517-2-2 - Emergency reporting requirements

Current through Vol. 41, No. 20, July 1, 2024
(a)
				Every practicing physician and clinical laboratory that is utilizing, or has
				utilized, an FDA-approved test, including an emergency use authorization test,
				for human diagnostic purposes of novel coronavirus, shall submit reports to
				OSDH in a manner, format, and frequency prescribed by the State Commissioner of
				Health of all test results, both positive and negative.
(b) Hospitals and Physician Clinics operating
				in the State of Oklahoma shall submit the following critical data to OSDH in a
				manner, format, and frequency prescribed by the State Commissioner of Health:
(1) The number of patients in the hospital
				receiving treatment for novel coronavirus;
(2) The number of patients receiving
				treatment for novel coronavirus who are currently admitted to the ICU;
				and
(3) The novel coronavirus
				vaccination status of patients in the hospital receiving treatment for novel
				coronavirus.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 517 - Novel Coronavirus Regulations › Subchapter 3 - Hospital Licensed Bed Capacity › Section 310:517-3-1 - Procedures to expand or modify licensed bed capacity

Current through Vol. 41, No. 20, July 1, 2024
(a) A hospital's licensed bed capacity can be
				expanded and/or modified, if it submits a letter to the Department that is
				signed by an authorized hospital authority, notarized and includes the
				following statements:
(1) the hospital
				attests that its emergency preparedness plan includes the expanded and/ or
				modified bed plan and is approved by its governing body;
(2) the hospital attests the location of the
				modified and/or expanded beds. The location must include:
(A) the building name and floor number if the
				modified and/or expanded beds are on the hospital's campus; or
(B) the physical address if the modified
				and/or expanded beds are not on the hospital's campus.
(3) if the hospital is also participating in
				Centers for Medicare & Medicaid Services' (CMS) Hospital Without Walls
				program (program), then the hospital attests:
(A) that its governing body has approved of
				its participation in the program;
(B) that it is participating in accordance
				with CMS requirements; and
(C) that
				the portions of the program that it is participating in is not in conflict with
				state statute.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 520 - Communicable Diseases in Schools Regulations › Section 310:520-1-2 - Quarantinable diseases

Current through Vol. 41, No. 20, July 1, 2024
The following diseases listed in this Chapter are declared
				quarantinable for both the cases and contacts:
(1) Smallpox
(2) Yellow Fever
(3) Cholera
(4) Plague
Second Annotated Edition, International Health Regulations,
				1969, (published in 1974).
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 520 - Communicable Diseases in Schools Regulations › Section 310:520-1-3 - Duty of school personnel

Current through Vol. 41, No. 20, July 1, 2024
(a) An
			 important part of a school health program is the prevention and control of
			 communicable diseases. The teacher is in a strategic position to detect
			 beginning symptoms if illness by the careful and continuous observation of
			 children in the classroom. There are three general measures which school
			 personnel can use to prevent the spread of disease:
(1) Oklahoma law requires parents to provide
			 proper and necessary immunizations for their children, particularly diphtheria,
			 whooping cough, tetanus, polio, rubella and measles during the preschool age.
			 All schools are required to maintain immunization records or exemptions on each
			 student.
(2) Encourage parents to
			 keep sick children at home.
(3)
			 Isolate pupils who appear to be ill and make preparations to send them home.
Good health is more important than a perfect attendance
				record.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 520 - Communicable Diseases in Schools Regulations › Section 310:520-1-4 - Diseases for which children should be excluded

Current through Vol. 41, No. 20, July 1, 2024
(a) Diseases for which children should be
			 excluded are shown on Appendix A of this Chapter. These are suggested periods
			 of exclusion and can be modified on the circumstances surrounding the
			 problem.
(b) When school of
			 officials have reasonable doubt as to the contagiousness of any person who has
			 been excluded from school for an infectious diseases, they may require a
			 written statement from the county health department director, county
			 superintendent of health, school nurse, or a private physician before the
			 person is permitted to reenter school.
(c) The superintendent, teacher, or other
			 official in charge of any school may exclude any child suffering from or
			 exhibiting the following symptoms:
(1) fever
			 alone, 100 degrees Fahrenheit;
(2)
			 sore throat or tonsillitis;
(3) any
			 eruption of the skin, or rash;
(4)
			 any nasal discharge accompanied by fever;
(5) a severe cough, producing phlegm;
			 or
(6) any inflammation of the eyes
			 or lids.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 1 - General Provisions › Section 310:521-1-1 - Purpose and authority

Current through Vol. 41, No. 20, July 1, 2024
The purpose of this chapter is to establish the rules for the
				  control and treatment of communicable disease in Oklahoma. The Commissioner of
				  Health has the authority to control, suppress, or prevent the occurrence or
				  spread of any communicable, contagious or infectious disease, provide for the
				  segregation and isolation of persons having or suspected of having any such
				  disease, and may designate places of quarantine or isolation under Title 63
				  O.S. §
									1-106.
				  The Board of Health has authority to adopt rules to aid in the prevention and
				  control of communicable diseases under Title 63 O.S. §
									1-502.
Added at 19 Ok Reg 2075,
				  eff 6-27-02; Amended at 25 Ok Reg 1148, eff
				  5-25-08
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 3 - Tuberculosis › Section 310:521-3-1 - Specific authority

Current through Vol. 41, No. 20, July 1, 2024
Tuberculosis control and treatment is specifically delegated
				  to the Oklahoma State Department of Health in 63 O.S. 1-401 through
				  1-410.
Added at 19 Ok Reg 2075,
				  eff 6-27-02; Amended at 25 Ok Reg 1148, eff
				  5-25-08
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 3 - Tuberculosis › Section 310:521-3-2 - Definitions

Current through Vol. 41, No. 20, July 1, 2024
The following words and terms, when used in the Subchapter,
				  shall have the following meaning, unless the context clearly indicates
				  otherwise:
"Tuberculosis treatment"
means tuberculosis
				  therapy with an American Thoracic Society/Centers for Disease Control and
				  Prevention recommended regimen or other regimen as prescribed or approved by
				  the Commissioner.
Added at 19 Ok Reg 2075,
				  eff 6-27-02; Amended at 24 Ok Reg 1981, eff 6-25-07; Amended at 25 Ok Reg 1148,
				  eff 5-25-08
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 3 - Tuberculosis › Section 310:521-3-3 - Standards of tuberculosis treatment

Current through Vol. 41, No. 20, July 1, 2024
(a)
				The Commissioner shall establish surveillance to identify all cases of
				tuberculosis in Oklahoma. All tuberculosis suspects shall be investigated to
				establish or exclude the diagnosis of tuberculosis disease.
(b) A person with tuberculosis in a
				contagious state will remain in isolation until non-contagious criteria are
				met.
(c) The Commissioner shall:
(1) Review the Tuberculosis treatment regimen
				for each person with active or suspected tuberculosis,
(2) Make recommendations for change, as
				indicated, and
(3) Establish the
				anticipated length of therapy.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 3 - Tuberculosis › Section 310:521-3-4 - Completion of tuberculosis treatment

Current through Vol. 41, No. 20, July 1, 2024
Completion of tuberculosis treatment occurs when the
				  prescribed number of doses have been taken within the appropriate length of
				  time for the established regimen, as determined by the
				  Commissioner.
Added at 19 Ok Reg 2075,
				  eff 6-27-02; Amended at 25 Ok Reg 1148, eff
				  5-25-08
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 3 - Tuberculosis › Section 310:521-3-5 - Alteration to treatment regimen

Current through Vol. 41, No. 20, July 1, 2024
Alteration in the prescribed treatment regimen may be
				  necessitated based on drug hypersensitivity, drug resistance, drug toxicity,
				  concurrent therapy with other drugs, or other disease
				  conditions.
Added at 19 Ok Reg 2075,
				  eff 6-27-02; Amended at 25 Ok Reg 1148, eff
				  5-25-08
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 5 - HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immunodeficiency Syndrome) › Section 310:521-5-1 - Specific authority

Current through Vol. 41, No. 20, July 1, 2024
HIV/AIDS prevention and control is specifically delegated to
				  the Oklahoma State Department of Health in 63 O.S., Section
				  1-502.
Added at 24 Ok Reg 1981,
				  eff 6-25-07
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 5 - HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immunodeficiency Syndrome) › Section 310:521-5-2 - Definitions

Current through Vol. 41, No. 20, July 1, 2024
The following words and terms, when used in the Subchapter,
				  shall have the following meaning, unless the context clearly indicates
				  otherwise:
"AIDS"
means Acquired Immunodeficiency Syndrome
				  and is the most severe manifestation of infection with the Human
				  Immunodeficiency Virus (HIV). The Centers for Disease Control and Prevention
				  (CDC) lists numerous opportunistic infections and neoplasms (cancers) that, in
				  the presence of HIV infection, constitute an AIDS diagnosis.
"Abstinence"
means the absence of any sexual
				  activity, which includes oral sex, anal sex or vaginal sex.
"Barrier protection"
means the use of a latex
				  condom during sexual activity.
"HAART"
means Highly Active Antiretroviral
				  Therapy, which is the combination of several antiretroviral medications used to
				  slow the rate at which HIV multiplies in the body.
"HIV positive"
means a person has tested
				  positive, using a Western Blot confirmatory test, for HIV antibodies, the virus
				  known to cause AIDS.
"HIV/STD Service surveillance section"
means the
				  unit of the Department tasked with the duty to process reports and information
				  concerning the incidence and occurrence of sexually transmitted disease
				  discovered or reported in Oklahoma.
"Opportunistic infection"
means infections,
				  which are rarely seen in those with normal immune systems, but are deadly to
				  those people who have AIDS and a compromised immune system.
"PCRS"
means Partner Counseling Referral
				  Services, which are offered by the OSDH HIV/STD Service to persons infected
				  with HIV and their sexual partners to assist with informing their sexual
				  partners about potential exposure to HIV.
"Retrovirus"
means RNA (ribonucleic acid) virus.
				  Retroviruses replicate (duplicate) by making a DNA (deoxyribonucleic acid) copy
				  of their RNA. It is the DNA genes that allow the virus to replicate in the
				  human body.
"Sexual activity"
means any activity, which
				  includes oral sex, anal sex, or vaginal sex.
"Transmission activity"
means activity that
				  involves the sharing or use of an instrument or device that is invasive or
				  pierces the epidermis.
"Viral load"
means the relative amount of human
				  immunodeficiency virus in a person's body.
Added at 24 Ok Reg 1981,
				  eff 6-25-07
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 5 - HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immunodeficiency Syndrome) › Section 310:521-5-3 - Standards of HIV/AIDS prevention and treatment

Current through Vol. 41, No. 20, July 1, 2024
(a) The Commissioner shall establish
				surveillance to identify all cases of HIV or AIDS in Oklahoma. All persons
				suspected of having AIDS or being HIV positive shall be investigated to
				establish or exclude the diagnosis of AIDS or being HIV positive.
(b) All health care providers, laboratories
				and county health departments are required to notify HIV/STD Service
				surveillance section of all reported cases of HIV and AIDS within 24 hours of
				diagnosis or notice. Upon receipt of reports to the surveillance section, the
				information will be entered into the HIV/AIDS database and a Disease
				Intervention Specialist (DIS) will be assigned to the report for case
				investigation and performance of PCRS.
(c) PCRS shall, at a minimum, include
				assisting HIV positive persons with informing their partners about potential
				exposure to HIV, how the risk of exposure can be decreased or minimized, or if
				already infected, how transmission to others may be prevented or avoided, and
				to information that will aid the infected person and his partners to gain
				access to counseling, testing, medical treatment, prevention and other
				services. Additionally, PCRS shall include any information that is generally
				scientifically accepted regarding measures that can be adopted or implemented
				to prevent the transmission of HIV or AIDS, including:
(1) Abstinence from sexual
				activity.
(2) If abstinence is not
				practiced, the correct use of an effective barrier protection device such as a
				latex condom.
(3) Refraining from
				sharing intravenous needles or other invasive drug injection devices.
(4) Refraining from the donation of blood,
				plasma, body organs or other tissue or semen.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 7 - Isolation or Quarantine › Section 310:521-7-1 - Examination

Current through Vol. 41, No. 20, July 1, 2024
The Commissioner may issue an order for the examination of
				  any individual upon the suspicion or confirmation that said individual has a
				  communicable disease. Such examination may include a clinical examination, a
				  specific diagnostic test or tests, or a specific laboratory test or tests. The
				  purpose of such examination(s) and/or test(s) is to determine the presence of
				  the suspected infectious organism or the presence of indicators of the
				  suspected infectious organism, and to determine the contagious state of the
				  individual to the extent possible.
Added at 25 Ok Reg 1148,
				  eff 5-25-08
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 7 - Isolation or Quarantine › Section 310:521-7-2 - Treatment

Current through Vol. 41, No. 20, July 1, 2024
The Commissioner may issue an order for the treatment of any
				  individual suspected or confirmed to have a communicable disease. The
				  Commissioner may also order the treatment of any individual or individuals
				  exposed to certain infectious agents. Such treatment plans will be according to
				  procedures developed within the Department.
Added at 25 Ok Reg 1148,
				  eff 5-25-08
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 7 - Isolation or Quarantine › Section 310:521-7-3 - Isolation or quarantine

Current through Vol. 41, No. 20, July 1, 2024
(a)
Isolation.
The Commissioner may issue an order for the isolation
				of any individual or group of individuals upon determination:
(1) That such individual or individuals who
				are reasonably known or suspected to have a communicable disease constituting a
				biologic public health threat and who remain within the transmission period for
				said disease; and
(2) That
				isolation is the necessary means to control the spread of the agent and the
				disease constituting a biologic public health threat.
Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 521 - Control and Treatment of Communicable Disease › Subchapter 7 - Isolation or Quarantine › Section 310:521-7-4 - Means of isolation or quarantine

Current through Vol. 41, No. 20, July 1, 2024
The Department shall recommend to the Commissioner the
				  appropriate means of isolation or quarantine, which shall generally be the
				  least restrictive means that effectively protects unexposed and susceptible
				  individuals. The place of isolation selected shall meet such infection control
				  standards that it effectively complies with nationally accepted guidelines for
				  the prevention of transmission of the infectious agent. The place of quarantine
				  selected shall allow the most freedom of movement and communication with family
				  members and other contacts without allowing transmission of the suspected
				  infectious agent to others.
Added at 25 Ok Reg 1148,
				  eff 5-25-08